Literature DB >> 12529715

Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients.

Y Cetin Kocaefe1, Sevim Erdem, Meral Ozgüç, Ersin Tan.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) is a rare autosomal recessive neurologic disorder characterised by multiple mitochondrial DNA deletions. In this study, five Turkish MNGIE patients are investigated for mtDNA deletions and TP gene mutations. The probands presented all the clinical criteria of the typical MNGIE phenotype; the muscle biopsy specimens also confirmed the diagnosis with ragged red fibres and cytochrome C oxidase (COX) negative fibres. The mitochondrial DNA analysis revealed no deletions in the probands' skeletal muscle samples. We have identified four novel mutations in the TP gene while one of the patients also harboured a nucleotide change, which was previously reported as a mutation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529715     DOI: 10.1038/sj.ejhg.5200908

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

2.  Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features.

Authors:  W M M Schüpbach; K Madhavi Vadday; A Schaller; C Brekenfeld; L Kappeler; J F Benoist; C Nguyen-Thi Xuan-Huong; J M Burgunder; F Seibold; S Gallati; H P Mattle
Journal:  J Neurol       Date:  2007-02-09       Impact factor: 4.849

Review 3.  Mitochondrial Neurogastrointestinal Encephalomyopathy Caused by Thymidine Phosphorylase Enzyme Deficiency: From Pathogenesis to Emerging Therapeutic Options.

Authors:  Rana Yadak; Peter Sillevis Smitt; Marike W van Gisbergen; Niek P van Til; Irenaeus F M de Coo
Journal:  Front Cell Neurosci       Date:  2017-02-15       Impact factor: 5.505

4.  Targeted next generation sequencing with an extended gene panel does not impact variant detection in mitochondrial diseases.

Authors:  Morgane Plutino; Annabelle Chaussenot; Cécile Rouzier; Samira Ait-El-Mkadem; Konstantina Fragaki; Véronique Paquis-Flucklinger; Sylvie Bannwarth
Journal:  BMC Med Genet       Date:  2018-04-07       Impact factor: 2.103

Review 5.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

Review 6.  Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1).

Authors:  Massimiliano Filosto; Stefano Cotti Piccinelli; Filomena Caria; Serena Gallo Cassarino; Enrico Baldelli; Anna Galvagni; Irene Volonghi; Mauro Scarpelli; Alessandro Padovani
Journal:  J Clin Med       Date:  2018-10-26       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.